CMPX – compass therapeutics, inc. (US:NASDAQ)

News

Compass Therapeutics (NASDAQ:CMPX) was downgraded by analysts at Wall St
Compass Therapeutics (NASDAQ:CMPX) was given a new $13.00 price target on by analysts at Canaccord Genuity Group Inc..
Compass Therapeutics (NASDAQ:CMPX) was upgraded by analysts at Wall Stre
Compass Therapeutics: Exciting Clinical Updates Inbound For 2026 [Seeking Alpha]
Compass Therapeutics, Inc. (CMPX): A Bull Case Theory [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com